Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Sarcoma 1Other 1

Conditions

Neoplasms 2Stomatitis 1Sarcoma 1Mucositis 1Kidney Diseases 1

Interventions

Gemcitabine 53Bevacizumab 52Cyclophosphamide 49Docetaxel 42Carboplatin 40pembrolizumab 37Paclitaxel 36Fluorouracil 36Cisplatin 35Radiotherapy 31Oxaliplatin 31Capecitabine 29Irinotecan 28Dexamethasone 27Leucovorin 25Cetuximab 25Nivolumab 24Doxorubicin 22Drug Therapy 21Erlotinib Hydrochloride 20Pemetrexed 19durvalumab 18trametinib 17fludarabine 16atezolizumab 16Trastuzumab 16Sunitinib 16Rituximab 16Prednisone 16Sorafenib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Neoplasms × Sodium Bicarbonate × Clear all
NCT03348826 2020-09-16

Study of Sodium Bicarbonate in Restoring Blocked Catheters

University Health Network, Toronto

Phase 2 Withdrawn
Tumor-Agnostic

Neoplasms

NCT00965172 2012-03-22

Caphosol in Sarcoma Patients With Mucositis

M.D. Anderson Cancer Center

Phase 2 Completed
30 enrolled
OtherSarcoma

Neoplasms, Sarcoma, Stomatitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡